Phillip Dougherty

ARID5B regulates metabolic programming in human adaptive NK cells

Bin Zhang, Cheng-Ying Wu, Jeffrey S. Miller, 2018, The Journal of experimental medicine.

GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity.

Paul C. Rogers, Bin Zhang, Jeffrey S. Miller, 2017, Cancer research.

A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma

S. Barsky, D. Vallera, P. Dougherty, 2013, Targeted Oncology.

Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells

J. Miller, D. Vallera, M. Gleason, 2016, Targeted Oncology.